Julien Calderaro, MD, PhD

Julien Calderaro, MD, PhD

Articles by Julien Calderaro, MD, PhD

Julien Calderaro, MD, PhDHepatocellular Carcinoma | March 13, 2025
Dr. Julien Calderaro explains the potential of AI to serve as a biomarker of sensitivity to atezolizumab plus bevacizumab.
View More